Furthermore, because CCK to a variable extent is expressed in neuroendocrine tumors and may function as tumor marker, a short presentation of the oncogenetic occurrence of CCK may have clinical interest (for reviews, see refs. [173, 174]). This evidence concerns the gene CCK and neuroendocrine neoplasm.